Chronic Inflammatory Demyelinating Polyneuropathy After Therapy With Infliximab Biosimilar

Chronic Inflammatory Demyelinating Polyneuropathy After Therapy With Infliximab Biosimilar

Tumor necrosis factor-α inhibitors are monoclonal antibodies that are commonly used in the treatment of inflammatory bowel disease. A rare side effect of these biological agents is chronic inflammatory demyelinating polyneuropathy, which is a debilitating disease characterized by weakness, sensory d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ACG case reports journal 2023-02, Vol.10 (2), p.e00993-e00993
Hauptverfasser: Larson, Jessica, Twohig, Patrick, Hutchins, Kathryn
Format: Artikel
Sprache:eng
Schlagworte:
Case Report
Inflammatory Bowel Disease
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e00993
container_issue 2
container_start_page e00993
container_title ACG case reports journal
container_volume 10
creator Larson, Jessica
Twohig, Patrick
Hutchins, Kathryn
description Tumor necrosis factor-α inhibitors are monoclonal antibodies that are commonly used in the treatment of inflammatory bowel disease. A rare side effect of these biological agents is chronic inflammatory demyelinating polyneuropathy, which is a debilitating disease characterized by weakness, sensory dysfunction, and diminished or absent reflexes. We present the first reported case of chronic inflammatory demyelinating polyneuropathy after treatment with the tumor necrosis factor-α inhibitor biosimilar, infliximab-dyyp (Inflectra).
doi_str_mv 10.14309/crj.0000000000000993
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9946395</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>36846359</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3536-4b4b65d2a891c39cc6cd160201934b05c7fde718b7525ba343d9ad7a78a30f4b3</originalsourceid><addsrcrecordid>eNpdkd9OwyAUxonRqFEfQdMX6IQeoOPGZM6_iYleaEy8IZTSFaVloZ2zby86XabcADnf9x3OD4SOCR4RClic6vA6wptLCNhC-xlkPIWMwfbGeQ8ddd1r1BDKcxBkF-0BH1MOTOyjl2kdfGt1cttWTjWN6n0YkgvTDMbZVvW2nSUP3g2tWQQ_V309JJOqNyF5rE1Q8yF5tn39bbYftlFFcm59ZxvrVDhEO5VynTn62Q_Q09Xl4_Qmvbu_vp1O7lINDHhKC1pwVmZqLIgGoTXXJeE4w0QALTDTeVWanIyLnGWsUEChFKrMVT5WgCtawAE6W-XOF0VjSm3aPign5yG-JwzSKyv_Vlpby5l_l0JECILFALYK0MF3XTDV2kuw_OYtI2_5n3f0nWw2Xrt-6UYBXQmW3kVm3ZtbLE2QtVGur2UcMWcix2mGM4gXjNOvT-LwCWQxjio</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Chronic Inflammatory Demyelinating Polyneuropathy After Therapy With Infliximab Biosimilar</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Larson, Jessica ; Twohig, Patrick ; Hutchins, Kathryn</creator><creatorcontrib>Larson, Jessica ; Twohig, Patrick ; Hutchins, Kathryn</creatorcontrib><description>Tumor necrosis factor-α inhibitors are monoclonal antibodies that are commonly used in the treatment of inflammatory bowel disease. A rare side effect of these biological agents is chronic inflammatory demyelinating polyneuropathy, which is a debilitating disease characterized by weakness, sensory dysfunction, and diminished or absent reflexes. We present the first reported case of chronic inflammatory demyelinating polyneuropathy after treatment with the tumor necrosis factor-α inhibitor biosimilar, infliximab-dyyp (Inflectra).</description><identifier>ISSN: 2326-3253</identifier><identifier>EISSN: 2326-3253</identifier><identifier>DOI: 10.14309/crj.0000000000000993</identifier><identifier>PMID: 36846359</identifier><language>eng</language><publisher>United States: Wolters Kluwer</publisher><subject>Case Report ; Inflammatory Bowel Disease</subject><ispartof>ACG case reports journal, 2023-02, Vol.10 (2), p.e00993-e00993</ispartof><rights>Wolters Kluwer</rights><rights>2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology.</rights><rights>2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3536-4b4b65d2a891c39cc6cd160201934b05c7fde718b7525ba343d9ad7a78a30f4b3</citedby><cites>FETCH-LOGICAL-c3536-4b4b65d2a891c39cc6cd160201934b05c7fde718b7525ba343d9ad7a78a30f4b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946395/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946395/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27915,27916,53782,53784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36846359$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Larson, Jessica</creatorcontrib><creatorcontrib>Twohig, Patrick</creatorcontrib><creatorcontrib>Hutchins, Kathryn</creatorcontrib><title>Chronic Inflammatory Demyelinating Polyneuropathy After Therapy With Infliximab Biosimilar</title><title>ACG case reports journal</title><addtitle>ACG Case Rep J</addtitle><description>Tumor necrosis factor-α inhibitors are monoclonal antibodies that are commonly used in the treatment of inflammatory bowel disease. A rare side effect of these biological agents is chronic inflammatory demyelinating polyneuropathy, which is a debilitating disease characterized by weakness, sensory dysfunction, and diminished or absent reflexes. We present the first reported case of chronic inflammatory demyelinating polyneuropathy after treatment with the tumor necrosis factor-α inhibitor biosimilar, infliximab-dyyp (Inflectra).</description><subject>Case Report</subject><subject>Inflammatory Bowel Disease</subject><issn>2326-3253</issn><issn>2326-3253</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpdkd9OwyAUxonRqFEfQdMX6IQeoOPGZM6_iYleaEy8IZTSFaVloZ2zby86XabcADnf9x3OD4SOCR4RClic6vA6wptLCNhC-xlkPIWMwfbGeQ8ddd1r1BDKcxBkF-0BH1MOTOyjl2kdfGt1cttWTjWN6n0YkgvTDMbZVvW2nSUP3g2tWQQ_V309JJOqNyF5rE1Q8yF5tn39bbYftlFFcm59ZxvrVDhEO5VynTn62Q_Q09Xl4_Qmvbu_vp1O7lINDHhKC1pwVmZqLIgGoTXXJeE4w0QALTDTeVWanIyLnGWsUEChFKrMVT5WgCtawAE6W-XOF0VjSm3aPign5yG-JwzSKyv_Vlpby5l_l0JECILFALYK0MF3XTDV2kuw_OYtI2_5n3f0nWw2Xrt-6UYBXQmW3kVm3ZtbLE2QtVGur2UcMWcix2mGM4gXjNOvT-LwCWQxjio</recordid><startdate>20230201</startdate><enddate>20230201</enddate><creator>Larson, Jessica</creator><creator>Twohig, Patrick</creator><creator>Hutchins, Kathryn</creator><general>Wolters Kluwer</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20230201</creationdate><title>Chronic Inflammatory Demyelinating Polyneuropathy After Therapy With Infliximab Biosimilar</title><author>Larson, Jessica ; Twohig, Patrick ; Hutchins, Kathryn</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3536-4b4b65d2a891c39cc6cd160201934b05c7fde718b7525ba343d9ad7a78a30f4b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Case Report</topic><topic>Inflammatory Bowel Disease</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Larson, Jessica</creatorcontrib><creatorcontrib>Twohig, Patrick</creatorcontrib><creatorcontrib>Hutchins, Kathryn</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>ACG case reports journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Larson, Jessica</au><au>Twohig, Patrick</au><au>Hutchins, Kathryn</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chronic Inflammatory Demyelinating Polyneuropathy After Therapy With Infliximab Biosimilar</atitle><jtitle>ACG case reports journal</jtitle><addtitle>ACG Case Rep J</addtitle><date>2023-02-01</date><risdate>2023</risdate><volume>10</volume><issue>2</issue><spage>e00993</spage><epage>e00993</epage><pages>e00993-e00993</pages><issn>2326-3253</issn><eissn>2326-3253</eissn><abstract>Tumor necrosis factor-α inhibitors are monoclonal antibodies that are commonly used in the treatment of inflammatory bowel disease. A rare side effect of these biological agents is chronic inflammatory demyelinating polyneuropathy, which is a debilitating disease characterized by weakness, sensory dysfunction, and diminished or absent reflexes. We present the first reported case of chronic inflammatory demyelinating polyneuropathy after treatment with the tumor necrosis factor-α inhibitor biosimilar, infliximab-dyyp (Inflectra).</abstract><cop>United States</cop><pub>Wolters Kluwer</pub><pmid>36846359</pmid><doi>10.14309/crj.0000000000000993</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2326-3253
ispartof ACG case reports journal, 2023-02, Vol.10 (2), p.e00993-e00993
issn 2326-3253
2326-3253
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9946395
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Case Report
Inflammatory Bowel Disease
title Chronic Inflammatory Demyelinating Polyneuropathy After Therapy With Infliximab Biosimilar
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T04%3A00%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chronic%20Inflammatory%20Demyelinating%20Polyneuropathy%20After%20Therapy%20With%20Infliximab%20Biosimilar&rft.jtitle=ACG%20case%20reports%20journal&rft.au=Larson,%20Jessica&rft.date=2023-02-01&rft.volume=10&rft.issue=2&rft.spage=e00993&rft.epage=e00993&rft.pages=e00993-e00993&rft.issn=2326-3253&rft.eissn=2326-3253&rft_id=info:doi/10.14309/crj.0000000000000993&rft_dat=%3Cpubmed_cross%3E36846359%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/36846359&rfr_iscdi=true